RBC Capital Mkts initiated coverage on Corbus Pharma with a new price target
$CRBP
Biotechnology: Pharmaceutical Preparations
Health Care
RBC Capital Mkts initiated coverage of Corbus Pharma with a rating of Outperform and set a new price target of $77.00